Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice

Lancet

Volumn 357, Issue 9250, 2001, Pages 89-95

  Roncaglioni, Maria Carla ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

ADULT; AGED; ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; FOLLOW UP; GENERAL PRACTICE; HEART DEATH; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PATIENT COMPLIANCE; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STROKE; TREATMENT OUTCOME;

EID: 0035852471     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)03539-X     Document Type: Article

References (33)

1. Clinical trials in general practice
2. Randomised controlled trials in general practice
3. Applying the results of clinical trials to patients in general practice: Perceived problems, strengths, assumptions, and challenges for the future
4. Application of evidence from randomised controlled trials to general practice
5. Randomised controlled trials in general practice: Lessons from a failure
6. Feasibility of a large prospective study in general practice: An Italian experience
7. The long-term prognostic significance of repeated blood pressure measurements in the elderly. SPAA (Studio sulla Pressione Arteriosa nell'Anziano) 10-year follow-up
8. Feasibility of a long-term low-sodium diet in mild hypertension
9. Epidemiological feasibility of cardiovascular primary prevention in general practice: A trial of vitamin E and aspirin
10. Vitamin E consumption and the risk of coronary disease in women
11. Vitamin E consumption and the risk of coronary heart disease in men
12. Randomised trial of prophylactic daily aspirin in British male doctors
13. Final report on the aspirin component of the ongoing Physicians' Health Study
14. Telephone interview for stroke outcome assessment
15. Thrombosis prevention trial: Randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk
16. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
17. Regression models and life tables (with discussion)
18. Treatment of hypertension in elderly patients
19. Unethical placebo assignment in clinical trials of thrombolysis
20. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other societies on coronary prevention
21. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
22. Determination of who may derive most benefit from aspirin in primary prevention: Subgroup results from a randomised controlled trial
23. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study
24. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
25. Vitamin E supplementation and cardiovascular events in high-risk patients
26. Do vitamin E and fish oil protect against ischaemic heart disease
27. GISSI-Prevenzione Trial
28. The antioxidant paradox
29. The case of GISSI in changing the attitudes and practice of Italian cardiologists
30. Financial interests constrain drug development
31. Could institutional clinical trials exist in Europe?